SlideShare a Scribd company logo
Areej Abu Hanieh
*
*Pneumonia usually developed with the patients who
has no contact to a medical facility.
*First , we should determine if patient should be treated
outpatient or inpatient .
*Outpatient care: able to take oral medications and
have adequate outpatient care
*º Inpatient care: based on severity-of-illness scores
(eg, CURB-65 criteria [confusion, uremia, respiratory
rate, low blood pressure, 65 years or older]) or
*prognostic models (eg, Pneumonia Severity Index
[PSI]) and professional judgment
*
Confusion
Uremia: BUN>7mmolL (20mgdl)
Respiratory rate: greater than or equal to 30/min
Low blood pressure: systolic <90 mm Hg;
or diastolic ≤60 mm Hg
Age 65 years or older
CURB-65 vs CRB-65
*
*PSI prognostic model:
* Assess 20 variables and assign points to each variable, this
model classifies patients to 5 classes;
*Risk class 1
*Risk class 2: <70
*Risk class 3: 71-90
*Risk class 4: 91-130
*Risk class 5:>130
*The PSI is less practical in a busy emergency-room setting
because of the need to assess 20 variables.
*If CURB-65 is from 0-1 , can be treated outpatient .
*Patients with CURB-65 score ≥2 require hospitalization or
aggressive outpatient care.
*If inpatient treatment required, determine if patient should
be admitted to ICU or general ward
*º ICU admission recommended: 1 major criteria or 3 minor
criteria are present , and CURB-65 of 3 and more .
*Patient who are admitted to ICU usually require:
* vasopressors for septic shock necessitating
* or if he has acute respiratory failure requiring intubation
and mechanical ventilation.
*
Hypothermia (<36°C)
• PaO2/FiO2 ratio ≤250
• Leukopenia (WBC <4000
cells/mm³)
• Multilobar infiltrates
• Confusion/disorientation
• Respiratory rate ≥30
breaths/min
• Uremia (BUN ≥20mg/dL)
• Thrombocytopenia (platelets
<100000 cells/mm³)
• Hypotension requiring
aggressive fluid resuscitation
• Other
considerations: hypoglycemia, acute
alcoholism/alcoholic withdrawal,
hyponatremia, unexplained metabolic
acidosis, elevated lactate, cirrhosis,
asplenia
*
• Invasive mechanical ventilation
• Septic shock requiring vasopressors
*
*Physical exam:
*º Crackles or rales, bronchial breath sounds, hypoxemia,
tachypnic
*º Signs/symptoms of cough, fever, sputum production,
pleuritic chest pain
*• Chest radiograph:
*º Hospitalized for suspected pneumonia but negative chest
radiograph: may receive empiric antibiotics with repeat
chest radiograph 24−48hrs later
*
* Lab tests:
*º Pretreatment blood culture and/or expectorated sputum
samples for culture and gram stain should be taken if:
* ICU admission, outpatient antibiotic therapy failure,
cavitary infiltrates, leukopenia, active alcohol abuse,
chronic severe liver and lung disease, asplenia,
positive Legionella or pneumococcal UAT result, pleural
effusion; optional for other indications
*º Tests mentioned above are optional in patients without
these conditions
*Severe CAP: should obtain blood culture, expectorated
sputum culture, urinary antigen tests for Legionella
pneumophila and S. pneumoniae; endotracheal aspirate
sample for intubated patients.
*
*
*Duration: minimum 5 days of treatment, should be afebrile
48−72hrs, and no more than 1 CAP associated sign of
clinical instability before discontinuing therapy.
*• Longer duration of therapy may be warranted in certain
circumstances (eg, initial therapy did not target identified
pathogen, extrapulmonary infections such as meningitis or
endocarditis)
*
*Temp ≤37.8°C
*º Heart rate ≤100 beats per min
*º Respiratory rate ≤24 breaths per min
*º Systolic blood pressure ≥90mmHg
*º Arterial 02 saturation ≥90% or pO2 ≥60mmHg
*º Maintain oral intake and normal mental status
*So signs of instability are the opposites of the signs (eg.
< , > )
*
*

More Related Content

What's hot

Mdr xdr TB
Mdr xdr TBMdr xdr TB
Management of community acquired pneumonia
Management of community acquired pneumoniaManagement of community acquired pneumonia
Management of community acquired pneumonia
Nahid Sherbini
 

What's hot (20)

Pathophysiology and clinical management of tuberculosis
Pathophysiology and clinical management of tuberculosisPathophysiology and clinical management of tuberculosis
Pathophysiology and clinical management of tuberculosis
 
Management of asthma
Management of asthmaManagement of asthma
Management of asthma
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Antimicrobial Surgical Prophylaxis
Antimicrobial Surgical ProphylaxisAntimicrobial Surgical Prophylaxis
Antimicrobial Surgical Prophylaxis
 
Mdr xdr TB
Mdr xdr TBMdr xdr TB
Mdr xdr TB
 
Acute meningitis for clinical pharmacy
Acute meningitis for clinical pharmacyAcute meningitis for clinical pharmacy
Acute meningitis for clinical pharmacy
 
Pharmacology of Antitubercular Drugs
 Pharmacology of Antitubercular Drugs  Pharmacology of Antitubercular Drugs
Pharmacology of Antitubercular Drugs
 
Septicemia
SepticemiaSepticemia
Septicemia
 
Chap 1 General principles involved in the management of poisoning
Chap 1 General principles involved in the management of poisoningChap 1 General principles involved in the management of poisoning
Chap 1 General principles involved in the management of poisoning
 
Septicemia
SepticemiaSepticemia
Septicemia
 
Pneumonia
Pneumonia Pneumonia
Pneumonia
 
Pharmacological Management of COPD
Pharmacological Management of COPD  Pharmacological Management of COPD
Pharmacological Management of COPD
 
MDR Pathogens: The Nightmare of Intensivists
MDR Pathogens: The Nightmare of IntensivistsMDR Pathogens: The Nightmare of Intensivists
MDR Pathogens: The Nightmare of Intensivists
 
COPD Exacerbations: Significance, Assessment, and Current Management
COPD Exacerbations:Significance, Assessment, and Current ManagementCOPD Exacerbations:Significance, Assessment, and Current Management
COPD Exacerbations: Significance, Assessment, and Current Management
 
Tuberculous Meningitis (TBM) by Dr. Neel Chugh
Tuberculous Meningitis (TBM)  by Dr. Neel ChughTuberculous Meningitis (TBM)  by Dr. Neel Chugh
Tuberculous Meningitis (TBM) by Dr. Neel Chugh
 
Anti tubercular drugs
Anti tubercular drugsAnti tubercular drugs
Anti tubercular drugs
 
COPD
COPDCOPD
COPD
 
Respiratory tract infections-PHARM.D
Respiratory tract infections-PHARM.DRespiratory tract infections-PHARM.D
Respiratory tract infections-PHARM.D
 
Anti Tubercular Drugs - Mechanism of Action and Adverse effects
Anti Tubercular Drugs - Mechanism of Action and Adverse effects Anti Tubercular Drugs - Mechanism of Action and Adverse effects
Anti Tubercular Drugs - Mechanism of Action and Adverse effects
 
Management of community acquired pneumonia
Management of community acquired pneumoniaManagement of community acquired pneumonia
Management of community acquired pneumonia
 

Similar to Community acquired pneumonia - Pharmacotherapy

Current Strategy in Management of Severe Sepsis.pptx
Current Strategy in Management of Severe Sepsis.pptxCurrent Strategy in Management of Severe Sepsis.pptx
Current Strategy in Management of Severe Sepsis.pptx
HoKimWah
 
Approach to Management of Fever & Sepsis (2) copy.pptx
Approach to Management of Fever & Sepsis (2) copy.pptxApproach to Management of Fever & Sepsis (2) copy.pptx
Approach to Management of Fever & Sepsis (2) copy.pptx
HarryArwin1
 

Similar to Community acquired pneumonia - Pharmacotherapy (20)

Indications_of_ICU_admission_and_ICU_management_of_COVID_19_NEW.pptx
Indications_of_ICU_admission_and_ICU_management_of_COVID_19_NEW.pptxIndications_of_ICU_admission_and_ICU_management_of_COVID_19_NEW.pptx
Indications_of_ICU_admission_and_ICU_management_of_COVID_19_NEW.pptx
 
Sepsis and Septic Shock.pptx
Sepsis and Septic Shock.pptxSepsis and Septic Shock.pptx
Sepsis and Septic Shock.pptx
 
Git j club PU bleed16.
Git j club PU bleed16.Git j club PU bleed16.
Git j club PU bleed16.
 
Olumide pidan d
Olumide pidan dOlumide pidan d
Olumide pidan d
 
Olumide pidan d
Olumide pidan dOlumide pidan d
Olumide pidan d
 
Acute exacerbation of COPD
Acute exacerbation of COPDAcute exacerbation of COPD
Acute exacerbation of COPD
 
Current Strategy in Management of Severe Sepsis.pptx
Current Strategy in Management of Severe Sepsis.pptxCurrent Strategy in Management of Severe Sepsis.pptx
Current Strategy in Management of Severe Sepsis.pptx
 
Sepsis
SepsisSepsis
Sepsis
 
sepsis.pptx
sepsis.pptxsepsis.pptx
sepsis.pptx
 
Sepsis and septic shock
Sepsis and septic shockSepsis and septic shock
Sepsis and septic shock
 
Approach to Management of Fever & Sepsis (2) copy.pptx
Approach to Management of Fever & Sepsis (2) copy.pptxApproach to Management of Fever & Sepsis (2) copy.pptx
Approach to Management of Fever & Sepsis (2) copy.pptx
 
Basis of surgical ICU
Basis of surgical ICU Basis of surgical ICU
Basis of surgical ICU
 
Sepsis and septic shock
Sepsis and septic shockSepsis and septic shock
Sepsis and septic shock
 
Weaning ventilator
Weaning ventilatorWeaning ventilator
Weaning ventilator
 
Upper gi bleeding
Upper gi bleeding  Upper gi bleeding
Upper gi bleeding
 
Pharmacotherapy of Lower respiratory tract infections
Pharmacotherapy of Lower respiratory tract infectionsPharmacotherapy of Lower respiratory tract infections
Pharmacotherapy of Lower respiratory tract infections
 
Git Gib 2010 plus Pictures.
Git Gib 2010 plus Pictures.Git Gib 2010 plus Pictures.
Git Gib 2010 plus Pictures.
 
POST OPERATIVE CARE : MAXILLO-FACIAL SURGERY
POST OPERATIVE CARE : MAXILLO-FACIAL SURGERYPOST OPERATIVE CARE : MAXILLO-FACIAL SURGERY
POST OPERATIVE CARE : MAXILLO-FACIAL SURGERY
 
Shock and management
Shock and managementShock and management
Shock and management
 
Post operative-care,gynecology and obstetric
Post operative-care,gynecology and obstetricPost operative-care,gynecology and obstetric
Post operative-care,gynecology and obstetric
 

More from Areej Abu Hanieh

More from Areej Abu Hanieh (20)

Announcement about my previous presentations - Thank you
Announcement about my previous presentations - Thank youAnnouncement about my previous presentations - Thank you
Announcement about my previous presentations - Thank you
 
Infection - penicillins
Infection - penicillinsInfection - penicillins
Infection - penicillins
 
Hospital acquired pneumonia
Hospital acquired pneumoniaHospital acquired pneumonia
Hospital acquired pneumonia
 
catheter related blood stream infection
catheter related blood stream infection catheter related blood stream infection
catheter related blood stream infection
 
Cellulitis - Treatment
Cellulitis - TreatmentCellulitis - Treatment
Cellulitis - Treatment
 
Carbapenems - Pharmacology
Carbapenems - PharmacologyCarbapenems - Pharmacology
Carbapenems - Pharmacology
 
Cephalosporins - Pharmacology
Cephalosporins - Pharmacology Cephalosporins - Pharmacology
Cephalosporins - Pharmacology
 
Sickle cell anemia
Sickle cell anemia Sickle cell anemia
Sickle cell anemia
 
Poisoning - Treatment
Poisoning - TreatmentPoisoning - Treatment
Poisoning - Treatment
 
Hypertensive urgencies and emergencies
Hypertensive urgencies and emergenciesHypertensive urgencies and emergencies
Hypertensive urgencies and emergencies
 
Diabetic ketoacidosis DKA
Diabetic ketoacidosis DKADiabetic ketoacidosis DKA
Diabetic ketoacidosis DKA
 
Asthma and COPD exacerbation - Emergency
Asthma and COPD exacerbation - Emergency  Asthma and COPD exacerbation - Emergency
Asthma and COPD exacerbation - Emergency
 
Acute decompensated heart failure
Acute decompensated heart failureAcute decompensated heart failure
Acute decompensated heart failure
 
Acute Coronary syndrome
Acute Coronary syndrome Acute Coronary syndrome
Acute Coronary syndrome
 
Glycemic Control - Diabetes Mellitus
Glycemic Control - Diabetes Mellitus Glycemic Control - Diabetes Mellitus
Glycemic Control - Diabetes Mellitus
 
Stress ulcer prophylaxis
Stress ulcer prophylaxis Stress ulcer prophylaxis
Stress ulcer prophylaxis
 
Pain in the ICU
Pain in the ICUPain in the ICU
Pain in the ICU
 
Deep Vein Thrombosis - DVT
Deep Vein Thrombosis  - DVTDeep Vein Thrombosis  - DVT
Deep Vein Thrombosis - DVT
 
Anti - Coagulants agents
Anti - Coagulants agentsAnti - Coagulants agents
Anti - Coagulants agents
 
Clinical use of neuromuscular blocking agents in critically ill patients - NMDA
Clinical use of neuromuscular blocking agents in critically ill patients - NMDAClinical use of neuromuscular blocking agents in critically ill patients - NMDA
Clinical use of neuromuscular blocking agents in critically ill patients - NMDA
 

Recently uploaded

Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
MedicoseAcademics
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
DR SETH JOTHAM
 

Recently uploaded (20)

5cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +852975043415cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +85297504341
 
End Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feelEnd Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feel
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 

Community acquired pneumonia - Pharmacotherapy

  • 2. *Pneumonia usually developed with the patients who has no contact to a medical facility.
  • 3. *First , we should determine if patient should be treated outpatient or inpatient . *Outpatient care: able to take oral medications and have adequate outpatient care *º Inpatient care: based on severity-of-illness scores (eg, CURB-65 criteria [confusion, uremia, respiratory rate, low blood pressure, 65 years or older]) or *prognostic models (eg, Pneumonia Severity Index [PSI]) and professional judgment
  • 4. * Confusion Uremia: BUN>7mmolL (20mgdl) Respiratory rate: greater than or equal to 30/min Low blood pressure: systolic <90 mm Hg; or diastolic ≤60 mm Hg Age 65 years or older CURB-65 vs CRB-65
  • 5. * *PSI prognostic model: * Assess 20 variables and assign points to each variable, this model classifies patients to 5 classes; *Risk class 1 *Risk class 2: <70 *Risk class 3: 71-90 *Risk class 4: 91-130 *Risk class 5:>130 *The PSI is less practical in a busy emergency-room setting because of the need to assess 20 variables.
  • 6. *If CURB-65 is from 0-1 , can be treated outpatient . *Patients with CURB-65 score ≥2 require hospitalization or aggressive outpatient care. *If inpatient treatment required, determine if patient should be admitted to ICU or general ward *º ICU admission recommended: 1 major criteria or 3 minor criteria are present , and CURB-65 of 3 and more . *Patient who are admitted to ICU usually require: * vasopressors for septic shock necessitating * or if he has acute respiratory failure requiring intubation and mechanical ventilation.
  • 7. * Hypothermia (<36°C) • PaO2/FiO2 ratio ≤250 • Leukopenia (WBC <4000 cells/mm³) • Multilobar infiltrates • Confusion/disorientation • Respiratory rate ≥30 breaths/min • Uremia (BUN ≥20mg/dL) • Thrombocytopenia (platelets <100000 cells/mm³) • Hypotension requiring aggressive fluid resuscitation • Other considerations: hypoglycemia, acute alcoholism/alcoholic withdrawal, hyponatremia, unexplained metabolic acidosis, elevated lactate, cirrhosis, asplenia
  • 8. * • Invasive mechanical ventilation • Septic shock requiring vasopressors
  • 9. * *Physical exam: *º Crackles or rales, bronchial breath sounds, hypoxemia, tachypnic *º Signs/symptoms of cough, fever, sputum production, pleuritic chest pain *• Chest radiograph: *º Hospitalized for suspected pneumonia but negative chest radiograph: may receive empiric antibiotics with repeat chest radiograph 24−48hrs later
  • 10. * * Lab tests: *º Pretreatment blood culture and/or expectorated sputum samples for culture and gram stain should be taken if: * ICU admission, outpatient antibiotic therapy failure, cavitary infiltrates, leukopenia, active alcohol abuse, chronic severe liver and lung disease, asplenia, positive Legionella or pneumococcal UAT result, pleural effusion; optional for other indications *º Tests mentioned above are optional in patients without these conditions *Severe CAP: should obtain blood culture, expectorated sputum culture, urinary antigen tests for Legionella pneumophila and S. pneumoniae; endotracheal aspirate sample for intubated patients.
  • 11. *
  • 12.
  • 13.
  • 14.
  • 15. * *Duration: minimum 5 days of treatment, should be afebrile 48−72hrs, and no more than 1 CAP associated sign of clinical instability before discontinuing therapy. *• Longer duration of therapy may be warranted in certain circumstances (eg, initial therapy did not target identified pathogen, extrapulmonary infections such as meningitis or endocarditis)
  • 16. * *Temp ≤37.8°C *º Heart rate ≤100 beats per min *º Respiratory rate ≤24 breaths per min *º Systolic blood pressure ≥90mmHg *º Arterial 02 saturation ≥90% or pO2 ≥60mmHg *º Maintain oral intake and normal mental status *So signs of instability are the opposites of the signs (eg. < , > )
  • 17. *
  • 18. *

Editor's Notes

  1. For outpatient: Take into considerations the ability to safely and reliably take oral medication and the availability of outpatient support resources.
  2. IDSA full treatment summary : https://www.infectiousdiseaseadvisor.com/home/clinical-charts/community-acquired-pneumonia-guidelines/